Literature DB >> 28069573

Relations Between Aortic Stiffness and Left Ventricular Mechanical Function in the Community.

Vanessa Bell1, Elizabeth L McCabe2, Martin G Larson2,3, Jian Rong3, Allison A Merz4, Ewa Osypiuk3, Birgitta T Lehman3, Plamen Stantchev3, Jayashri Aragam5, Emelia J Benjamin6,3,7, Naomi M Hamburg7,8, Ramachandran S Vasan6,3,7, Gary F Mitchell9, Susan Cheng10,4.   

Abstract

BACKGROUND: Aortic stiffness impairs optimal ventricular-vascular coupling and left ventricular systolic function, particularly in the long axis. Left ventricular global longitudinal strain (GLS) has recently emerged as a sensitive measure of early cardiac dysfunction. In this study, we investigated the relation between aortic stiffness and GLS in a large community-based sample. METHODS AND
RESULTS: In 2495 participants (age 39-90 years, 57% women) of the Framingham Offspring and Omni cohorts, free of cardiovascular disease, we performed tonometry to measure arterial hemodynamics and echocardiography to assess cardiac function. Aortic stiffness was evaluated as carotid-femoral pulse wave velocity and as characteristic impedance, and GLS was calculated using speckle tracking-based measurements. In multivariable analyses adjusting for age, sex, height, systolic blood pressure, augmentation index, left ventricular structure, and additional cardiovascular risk factors, increased carotid-femoral pulse wave velocity (B±SE: 0.122±0.030% strain per SD, P<0.0001) and characteristic impedance (0.090±0.029, P=0.002) were both associated with worse GLS. We observed effect modification by sex on the relation between characteristic impedance and GLS (P=0.004); in sex-stratified multivariable analyses, the relation between greater characteristic impedance and worse GLS persisted in women (0.145±0.039, P=0.0003) but not in men (P=0.73).
CONCLUSIONS: Multiple measures of increased aortic stiffness were cross-sectionally associated with worse GLS after adjusting for hemodynamic variables. Parallel reductions in left ventricular long axis shortening and proximal aortic longitudinal strain in individuals with a stiffened proximal aorta, from direct mechanical ventricular-vascular coupling, offers an alternative explanation for the observed relations.
© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

Entities:  

Keywords:  aortic stiffness; characteristic impedance; global longitudinal strain; left ventricle function; pulse wave velocity; ventricular/vascular coupling hemodynamics

Mesh:

Year:  2017        PMID: 28069573      PMCID: PMC5523643          DOI: 10.1161/JAHA.116.004903

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


Introduction

Left ventricular (LV) function can be evaluated using directional components of myocardial deformation or strain. Longitudinal LV strain (also referred to as global longitudinal strain, GLS) appears to be a sensitive measure of impaired LV systolic function1, 2, 3 and has been shown in several studies to be better than ejection fraction at predicting cardiovascular disease events and death.4, 5, 6, 7 During systole, longitudinal shortening of the LV produces aortic displacement8, 9, 10 and stretches the ascending aorta.11 The force required to produce longitudinal strain of the aorta represents an often overlooked form of direct mechanical load on the LV that may have important implications for the relation between aortic stiffness and LV systolic function, particularly in the long axis.11, 12 Alterations in both LV and aortic physiology may play an important role in predisposition to heart failure and especially heart failure with preserved ejection fraction (HFpEF). Whereas HFpEF is almost as common as heart failure with reduced ejection fraction, HFpEF has proven relatively refractory to treatment in a number of randomized clinical trials,13, 14, 15 underscoring the importance of efforts to better understand its pathophysiology. Interestingly, HFpEF has been related to both reduced GLS and increased aortic stiffness in a number of prior studies.3, 7, 16, 17, 18, 19, 20 Furthermore, both HFpEF and aortic stiffness are prevalent in older individuals, particularly women,16, 17 suggesting possible pathophysiologic links between aortic stiffness and subclinical alterations in LV systolic function that may promote the development of HFpEF in susceptible individuals. Therefore, to further clarify the interrelations of large artery hemodynamics and alterations in LV systolic function, we investigated the association between aortic stiffness and GLS in a large, community‐based sample free of overt cardiovascular disease.

Methods

Study Sample

Participant selection criteria and the design of the Framingham Offspring and the Framingham Omni studies have been previously described.21, 22, 23 Offspring Study participants who attended their eighth examination (2005–2008) and Omni Study participants who attended their third examination (2007–2008) underwent a standardized medical history and examination (N=3319), and underwent routine echocardiography (N=3185) with digital image acquisition using a Hewlett‐Packard 5500 machine (Philips Healthcare, Andover, MA). A total of 3086 individuals had echocardiographic images deemed appropriate for speckle‐tracking analyses based on the following criteria: ≤1 segment of dropout for any of the predefined views (apical 2‐chamber, apical 4‐chamber, or parasternal short‐axis at the level of the midventricle) and absence of arrhythmia during image capture.24 From this sample, we excluded individuals in hierarchical, non‐exclusive fashion for the following reasons: prior history of cardiovascular disease (N=252), prevalent atrial fibrillation (N=124), valvular heart disease (N=63), missing covariate data (N=12), and missing carotid–femoral pulse wave velocity (CFPWV, N=140), resulting in a final sample of 2495 participants eligible for the present investigation. The Institutional Review Board of Boston University Medical Campus approved the study protocols, and all participants provided written informed consent.

Clinical Evaluation and Definitions

Medical history, physical examination, and electrocardiography were performed routinely at each Framingham Heart Study examination.22 Physician‐acquired blood pressures represent the mean of 2 auscultatory measurements obtained on the left arm of seated participants at the time of the Framingham clinic examination. The physician blood pressures were acquired using a mercury column sphygmomanometer and a standardized protocol with excellent measurement reproducibility. Body mass index was calculated by dividing weight in kilograms by the square of the height in meters. Blood glucose was measured in the morning after participants had fasted overnight. Criteria for diabetes mellitus were a blood glucose level of 126 mg/dL (7.0 mmol/L) or greater, or the use of medications to treat diabetes. Smoking was defined as regular use of cigarettes in within the year preceding the Framingham Heart Study visit.

Assessment of Noninvasive Hemodynamics

Hemodynamic data were acquired as previously described.25 Participants were studied in the supine position after 5 minutes of rest. Supine auscultatory brachial systolic and diastolic blood pressure at the time of tonometry (referred to as tonometric measures) were obtained using a computer‐controlled device. Arterial tonometry with simultaneous electrocardiography was obtained from brachial, radial, femoral, and carotid arteries using a custom tonometer. Next, 2‐dimensional echocardiographic images of the LV outflow tract were obtained from a parasternal long‐axis view followed by pulsed Doppler of the LV outflow tract from an apical 5‐chamber view. Tonometric, electrocardiographic, and echocardiographic data were digitized during the primary acquisition and transferred to the core laboratory (Cardiovascular Engineering, Inc, Norwood, MA) for analysis by trained analyzers blinded to participant characteristics. Tonometry waveforms were signal‐averaged using the electrocardiographic R‐wave as a fiducial point.25 Since tonometry and echocardiography were performed during the same examination session for each participant, blood pressure measurements recorded as part of the tonometry assessment are also considered contemporary with the echocardiographic assessment. Cuff systolic and diastolic pressures obtained at the time of tonometry were used to calibrate the peak and trough of the signal‐averaged brachial pressure waveform. Mean arterial pressure was calculated by integration of the calibrated brachial pressure waveform.26 Diastolic pressure and mean arterial pressure were then used to calibrate carotid pressure tracings.27 Calibrated carotid pressure was used as a surrogate for central pressure.27 CFPWV was calculated from carotid and femoral pressure waveforms, and body surface measurements were corrected for parallel transmission by subtracting the distance from suprasternal notch to carotid artery, from the distance from suprasternal notch to femoral artery, as previously described.28 Reproducibility of the major tonometric measures in our laboratory has been previously reported.29 In a random sample of 50 cases that were blindly re‐analyzed by a second observer, the correlation coefficient was r=0.972 for CFPWV and r=0.997 for augmentation index (AI). Characteristic impedance (Zc) was calculated from the ratio of change in carotid pressure and the change in flow in the proximal aorta during early systole.26 Early systole was defined as the time interval between the onset of flow and the time that flow reaches 95% of its maximum value.

Assessment of Cardiac Strain

We used an off‐line speckle‐tracking software package (2D Cardiac Performance Analysis v1.1; TomTec Imaging Systems, Unterschleißheim, Germany) to analyze LV cardiac strain in each of the pre‐defined 2‐dimensional views (apical 2‐chamber, apical 4‐chamber, and midventricular parasternal short‐axis) according to a standardized protocol.24 The TomTec 2D software package allows for performing strain measurements according to an established speckle‐tracking algorithm that has been validated with sonomicrometry as well as cardiac magnetic resonance imaging, as reported previously.30, 31, 32 GLS was calculated as the average of longitudinal strains from the 2‐ and 4‐chamber views and global circumferential strain (GCS) was calculated from the short‐axis view. Negative strain values indicate LV myofiber shortening. Excellent intra‐ and interobserver reproducibility for strain measures have been reported previously.24

Statistical Methods

Clinical, tonometric, and echocardiographic characteristics of the study sample were tabulated separately by sex. Negative inverse CFPWV and natural log‐transformed Zc were used in statistical analyses to minimize heteroscedasticity and normalize distributions. We used multivariable‐adjusted regression models to quantify associations between each of the primary hemodynamic measures (CFPWV and Zc; independent variables) and each LV cardiac strain measure (GLS and GCS; dependent variables). We adjusted for (1) cohort (Omni versus Offspring), age, sex, and height; and (2) additionally for weight, glucose, total/high‐density lipoprotein cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate during tonometry, tonometric systolic blood pressure, and AI. To account for multiple testing performed with 2 primary aortic stiffness independent measures and 2 primary strain dependent measures, we used a conservative Bonferroni‐corrected statistical significance threshold of P<0.0125=(0.05/4). In secondary analyses, we repeated analyses with additional adjustment for LV mass, LV wall thickness, and LV end‐diastolic dimension. We also tested for modification of strain associations by age and sex. Figure models were performed with native units of CFPWV and Zc for easier interpretation of results and were not significantly different from models using transformed values. Figures were created using restricted cubic splines with knots at the 5th, 50th, and 95th percentiles. All analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC). The authors have full access to and take full responsibility for the integrity of the data. All authors read and agreed to the manuscript as written.

Results

Table 1 displays the clinical characteristics of men and women in the study sample. Table 2 presents the clinical characteristics of both included and excluded participants. Individuals excluded tended to be older, have higher body mass index, and a higher prevalence of diabetes mellitus and treatment for hypertension and dyslipidemia. Table 3 displays vascular and cardiac measures of men and women in the study sample. Men had a higher CFPWV and a larger LV structure, whereas women had a higher Zc and larger magnitudes of GLS and GCS.
Table 1

Sample Characteristics

VariablesMen (N=1065)Women (N=1430)
Age, y65±966±9
Nonwhite race/ethnicity, N (%)90 (8)147 (10)
Height, cm175±7161±6
Weight, kg87±1571±15
Body mass index, kg/m2 28.5±4.527.4±5.6
Seated blood pressure, mm Hg
Systolic129±16127±18
Diastolic76±1073±10
Glucose, mg/dL109±24102±20
Total/HDL cholesterol ratio3.7±1.13.3±1.0
Triglycerides, mg/dL a 101 (73, 144)99 (73, 135)
Diabetes mellitus, N (%)171 (16)130 (9)
Current smoker, N (%)82 (8)129 (9)
Hypertension treatment, N (%)543 (51)646 (45)
Lipid treatment, N (%)517 (49)578 (40)

Values are shown as means±SD or number (percent frequency) unless otherwise indicated. HDL indicates high‐density lipoprotein.

Median (25th, 75th percentile).

Table 2

Included Versus Excluded Sample Characteristics

VariablesIncluded (N=2495)Excluded (N=824)
Age, y65±971±10
Women, N (%)1430 (57)419 (51)
Nonwhite race/ethnicity, N (%)237 (10)61 (7)
Height, cm167±10167±10
Weight, kg78±1782±20
Body mass index, kg/m2 27.9±5.230.0±6.2
Seated blood pressure, mm Hg
Systolic128±17130±18
Diastolic74±1071±11
Glucose, mg/dL105±22112±30
Total/HDL cholesterol ratio3.5±1.03.5±1.1
Triglycerides, mg/dL a 100 (73, 138)107 (75, 153)
Diabetes mellitus, N (%)301 (12)179 (25)
Current smoker, N (%)211 (8)73 (9)
Hypertension treatment, N (%)1189 (48)619 (75)
Lipid treatment, N (%)1095 (44)490 (60)

Values are shown as means±SD or number (percent frequency) unless otherwise indicated. HDL indicates high‐density lipoprotein.

Median (25th, 75th percentile).

Table 3

Vascular and Cardiac Measures

VariablesMen (N=1065)Women (N=1430)
Tonometric measures
Heart rate, min−1 59±1061±10
Supine blood pressure, mm Hg
Systolic140±19140±20
Diastolic70±969±9
Mean98±1198±12
Pulse pressure70±1771±19
Carotid–femoral pulse wave velocity, m/s10.6±3.79.9±3.4
Negative inverse CFPWV, ms/m−103±28−110±29
Characteristic impedance (Zc), dyne·s/cm5 218±74262±104
Log‐characteristic impedance, dyne·s/cm5 5.3±0.35.5±0.4
Augmentation index10.5±10.516.9±12.5
Echocardiographic measures
LV wall thickness, cm2.1±0.21.8±0.2
LV end‐diastolic dimension, cm5.1±0.44.6±0.4
LV mass, g195.2±41.6139.8±30.8
LV ejection fraction, %65.7±6.869.1±6.3
Global longitudinal strain (GLS), %−19.7±2.9−21.5±3.2
Global circumferential strain (GCS), %−31.0±5.5−33.1±5.7

Values are shown as means±SD or number (percent frequency) unless otherwise indicated. CFPWV indicates carotid–femoral pulse wave velocity; LV, left ventricular.

Sample Characteristics Values are shown as means±SD or number (percent frequency) unless otherwise indicated. HDL indicates high‐density lipoprotein. Median (25th, 75th percentile). Included Versus Excluded Sample Characteristics Values are shown as means±SD or number (percent frequency) unless otherwise indicated. HDL indicates high‐density lipoprotein. Median (25th, 75th percentile). Vascular and Cardiac Measures Values are shown as means±SD or number (percent frequency) unless otherwise indicated. CFPWV indicates carotid–femoral pulse wave velocity; LV, left ventricular. Multivariable‐adjusted associations of the aortic stiffness measures (CFPWV and Zc) with LV strain measures (GLS and GCS) are shown in Table 4 and in Figures 1 and 2. Greater global aortic stiffness, as represented by CFPWV, was associated with worse (less negative) GLS in all models, and was associated with worse (less negative) GCS in the age‐, sex‐, and height‐adjusted model only (Table 4 and Figure 1). There was no significant effect modification by age or sex on the relations between CFPWV and either GLS or GCS (Table 5). Greater proximal aortic stiffness, as represented by Zc, was also associated with worse GLS and worse GCS in multivariable‐adjusted models (Table 4). Although there was no significant effect modification by age on these associations, or by sex on the associations of Zc with GCS, there was a significant sex interaction in models relating Zc with GLS (Table 5). In sex‐stratified analyses, Spearman correlation coefficients were calculated for the relations of pulse pressure with CFPWV and Zc: ρ=0.52 and 0.69, respectively, in men; ρ=0.57 and 0.71, respectively, in women. In secondary analyses of CFPWV and Zc with GLS and GCS additionally adjusting for serum creatinine as a measure of renal function, results were unchanged (data not shown).
Table 4

Multivariable‐Adjusted Associations of Hemodynamic Measures With Indices of LV Strain

Vascular MeasuresGlobal Longitudinal Strain (GLS)Global Circumferential Strain (GCS)
Coefficient (SE)a P ValueCoefficient (SE)a P Value
Negative inverse CFPWV
Model 10.211 (0.024)<0.00010.077 (0.026)0.003
Model 20.099 (0.029)0.00050.038 (0.031)0.22
Model 30.122 (0.030)<0.00010.063 (0.032)0.05
Log‐Zcb
Model 10.095 (0.023)<0.00010.051 (0.024)0.04
Model 20.082 (0.028)0.0030.080 (0.030)0.008
Model 30.090 (0.029)0.0020.109 (0.031)0.0005

Model 1 is adjusted for cohort, age, sex, and height. Model 2 is adjusted for the covariates in Model 1 plus weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, and augmentation index. Model 3 is adjusted for the covariates in Model 2 plus LV mass, LV wall thickness, and LV end‐diastolic dimension. CFPWV indicates carotid–femoral pulse wave velocity; HDL, high‐density lipoprotein; Zc, characteristic impedance; LV, left ventricular.

Coefficients denote estimated variation in the cardiac strain measure (dependent variable in units of SD) per 1 SD of the hemodynamic measure (independent variable). The sex‐pooled mean±SD of negative inverse CFPWV was −107±29 ms/m; thus, 1 SD higher negative inverse CFPWV corresponds to a reverse‐transformed difference of 3.5 m/s (the difference between −107 and −107+29 transformed back to native units). The sex‐pooled mean±SD for Log‐Zc was 5.4±0.4; thus, 1 SD higher Log‐Zc corresponds to an inverse transformed 1 SD difference of 95 dyne·s/cm5. Thus, Model 3 results indicate that a CFPWV that was 3.5 m/s higher than the mean would be associated with a 0.12 SD higher (worse) GLS.

Relations between Log‐Zc and GLS exhibited a sex‐interaction (Table 5). Analyses were therefore repeated for men and women separately (Model 2: Men −0.012 [0.041] P=0.77, Women 0.146 [0.037] P<0.0001; Model 3: Men 0.015 [0.043] P=0.73, Women: 0.145 [0.039] P=0.0003).

Figure 1

Multivariable adjusted associations between carotid–femoral pulse wave velocity (CFPWV) and (A) global longitudinal strain (GLS) and (B) global circumferential strain (GCS). GLS was significantly worse (less negative) with greater CFPWV, and GCS was significantly worse (less negative) with greater CFPWV. Analyses were adjusted for key covariates: cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, augmentation index, left ventricular mass, left ventricular wall thickness, and left ventricular diastolic dimension. The symbol Δ refers to difference in GLS or GCS compared to the median per CFPWV value. CL indicates confidence limit; HDL, high‐density lipoprotein.

Figure 2

Multivariable adjusted associations between characteristic impedance (Zc) and global longitudinal strain (GLS) in (A) men and (B) women and between Zc and global circumferential strain (GCS) in (C) men and (D) women. Greater Zc was not significantly associated with either GLS or GCS in men; by contrast, Zc was associated with significantly worse (less negative) GLS and GCS. Analyses were adjusted for key covariates: cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, augmentation index, left ventricular mass, left ventricular wall thickness, and left ventricular diastolic dimension. The symbol Δ refers to difference in GLS or GCS compared to the median per Zc value. CL indicates confidence limit; HDL, high‐density lipoprotein.

Table 5

Age and Sex Interactions in Multivariable‐Adjusted Associations

Vascular MeasuresLongitudinal Strain (GLS)Circumferential Strain (GCS)
Coefficient (SE)a P ValueCoefficient (SE)a P Value
Age interaction terms
Age×(negative inverse CFPWV)
Model 20.024 (0.044)0.580.026 (0.047)0.58
Model 30.065 (0.046)0.160.056 (0.049)0.25
Age×Log‐Zc
Model 2−0.0004 (0.041)0.990.022 (0.044)0.62
Model 30.009 (0.043)0.830.034 (0.045)0.45
Sex interaction terms
Sex×(negative inverse CFPWV)
Model 20.044 (0.039)0.27−0.065 (0.042)0.12
Model 30.049 (0.042)0.24−0.082 (0.044)0.06
Sex×Log‐Zc
Model 20.118 (0.040)0.0040.016 (0.044)0.72
Model 30.107 (0.042)0.010.021 (0.045)0.65

Model 2 is adjusted for cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, and augmentation index. Model 3 is adjusted for the covariates in Model 2 plus LV mass, LV wall thickness, and LV end‐diastolic dimension. CFPWV indicates carotid–femoral pulse wave velocity; GCS, global circumferential strain; GLS, global longitudinal strain; HDL, high‐density lipoprotein; LV, left ventricular; Zc, characteristic impedance.

Coefficients are for the age interaction term (older vs younger age was defined by the median age [65 years]) or the sex interaction term (testing for difference in slopes between women vs men) as independent measures in the multivariable models.

Multivariable‐Adjusted Associations of Hemodynamic Measures With Indices of LV Strain Model 1 is adjusted for cohort, age, sex, and height. Model 2 is adjusted for the covariates in Model 1 plus weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, and augmentation index. Model 3 is adjusted for the covariates in Model 2 plus LV mass, LV wall thickness, and LV end‐diastolic dimension. CFPWV indicates carotid–femoral pulse wave velocity; HDL, high‐density lipoprotein; Zc, characteristic impedance; LV, left ventricular. Coefficients denote estimated variation in the cardiac strain measure (dependent variable in units of SD) per 1 SD of the hemodynamic measure (independent variable). The sex‐pooled mean±SD of negative inverse CFPWV was −107±29 ms/m; thus, 1 SD higher negative inverse CFPWV corresponds to a reverse‐transformed difference of 3.5 m/s (the difference between −107 and −107+29 transformed back to native units). The sex‐pooled mean±SD for Log‐Zc was 5.4±0.4; thus, 1 SD higher Log‐Zc corresponds to an inverse transformed 1 SD difference of 95 dyne·s/cm5. Thus, Model 3 results indicate that a CFPWV that was 3.5 m/s higher than the mean would be associated with a 0.12 SD higher (worse) GLS. Relations between Log‐Zc and GLS exhibited a sex‐interaction (Table 5). Analyses were therefore repeated for men and women separately (Model 2: Men −0.012 [0.041] P=0.77, Women 0.146 [0.037] P<0.0001; Model 3: Men 0.015 [0.043] P=0.73, Women: 0.145 [0.039] P=0.0003). Multivariable adjusted associations between carotid–femoral pulse wave velocity (CFPWV) and (A) global longitudinal strain (GLS) and (B) global circumferential strain (GCS). GLS was significantly worse (less negative) with greater CFPWV, and GCS was significantly worse (less negative) with greater CFPWV. Analyses were adjusted for key covariates: cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, augmentation index, left ventricular mass, left ventricular wall thickness, and left ventricular diastolic dimension. The symbol Δ refers to difference in GLS or GCS compared to the median per CFPWV value. CL indicates confidence limit; HDL, high‐density lipoprotein. Multivariable adjusted associations between characteristic impedance (Zc) and global longitudinal strain (GLS) in (A) men and (B) women and between Zc and global circumferential strain (GCS) in (C) men and (D) women. Greater Zc was not significantly associated with either GLS or GCS in men; by contrast, Zc was associated with significantly worse (less negative) GLS and GCS. Analyses were adjusted for key covariates: cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, augmentation index, left ventricular mass, left ventricular wall thickness, and left ventricular diastolic dimension. The symbol Δ refers to difference in GLS or GCS compared to the median per Zc value. CL indicates confidence limit; HDL, high‐density lipoprotein. Age and Sex Interactions in Multivariable‐Adjusted Associations Model 2 is adjusted for cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, and augmentation index. Model 3 is adjusted for the covariates in Model 2 plus LV mass, LV wall thickness, and LV end‐diastolic dimension. CFPWV indicates carotid–femoral pulse wave velocity; GCS, global circumferential strain; GLS, global longitudinal strain; HDL, high‐density lipoprotein; LV, left ventricular; Zc, characteristic impedance. Coefficients are for the age interaction term (older vs younger age was defined by the median age [65 years]) or the sex interaction term (testing for difference in slopes between women vs men) as independent measures in the multivariable models. Given the significant sex interaction observed for the association between Zc and GLS, we performed sex‐stratified analyses. In analyses adjusting for clinical covariates including systolic blood pressure and AI, greater Zc was associated with worse GLS in women (0.146% [SE 0.037] strain per SD in log‐Zc, P<0.0001) but not in men (Table 4). In multivariable analyses with additional adjustment for conventional measures of LV structure, the association of greater Zc and worse GLS remained significant in women (0.145% [SE 0.039] strain per SD in log‐Zc, P=0.0003) and not in men (Table 4 and Figure 2).

Discussion

In a cross‐sectional community‐based cohort of middle‐aged and older adults, greater aortic wall stiffness, as evaluated by CFPWV, was associated with worse (less negative) GLS. Prior studies have investigated the extent to which hemodynamic load, represented by indices of aortic wave reflection, are related to advanced measures of LV function.33 By contrast, we focused our investigation on the extent to which aortic stiffness possibly confers a non‐hemodynamic effect on LV function, particularly in the long axis. CFPWV was related to GLS, but not GCS, in both men and women, consistent with the hypothesis that aortic stiffening imposes a direct mechanical load on long‐axis LV function. Zc was related to GLS in women only, suggesting that LV long‐axis function may be particularly sensitive to mechanical coupling with the proximal aorta in women. By contrast, short‐axis function was sensitive to Zc in men and women, suggesting that Zc contributes to elements of global hemodynamic load separate from systolic pressure and AI. The association between aortic wall stiffness (evaluated as either CFPWV or Zc) and GLS persisted after adjusting for systolic blood pressure and AI, indicating that the relation between aortic wall stiffness and LV long‐axis function may not be explained fully by potential effects of aortic stiffening on blood pressure and wave reflection. Increased aortic stiffness has been linked to impaired LV systolic function, particularly along the LV long axis.34, 35, 36, 37, 38, 39 The relation is often attributed to increased hemodynamic load imposed by stiffer arteries.36, 40 However, our observed relations between aortic stiffness measures and GLS persisted after adjusting for traditional measures of hemodynamic load. Direct mechanical ventricular–vascular coupling provides an alternative explanation for the observed relation between aortic stiffness and LV systolic function. Systolic contraction shortens the LV long axis by pulling the aortic annulus and sinotubular junction of the aorta towards the LV apex, which moves minimally during systole.8, 9, 11 The combination of aortic annulus displacement along with minimal movement of the aortic arch implies that there is considerable longitudinal stretch of the ascending aorta during systole.10, 11, 41 Aortic stretch increases from the beginning until the end of systole and imposes a progressive systolic load on the heart.9, 12 If the aorta stiffens, the heart must contract with greater long‐axis force in order to produce the same amount of aortic displacement; for a given LV contraction strength, a stiff aorta would be displaced and stretched less than a compliant aorta would. Therefore, LV long‐axis shortening and GLS may be reduced when pulling against a stiffer aorta because of a potential mechanical ventricular–vascular interaction. Both increased aortic stiffness and impaired GLS have been associated with impaired LV diastolic function in previous studies12, 19, 34, 35, 38, 42, 43, 44, 45, 46, 47 as well as in our cohort.48 The relation between aortic stiffness and diastolic function is often attributed to hemodynamic effects, while the relation between GLS and diastolic function has been attributed to recoil of contracted LV muscle fibers.49, 50 Recent studies have suggested that diastolic recoil of the aorta and left atrium, which are stretched during systole, facilitates LV filling and ejection.12, 51, 52, 53, 54, 55 The association between increased aortic stiffness and worse GLS observed in our study may relate to both the systolic and diastolic components of direct mechanical ventricular–vascular coupling and requires further study.48 Women tend to have greater aortic longitudinal strain, and better (more negative) GLS and LV ejection fraction than men even in older age.11, 56, 57, 58, 59 Despite having better apparent LV systolic function than men, older women are more likely to develop diastolic dysfunction and HFpEF.16, 17, 38, 60, 61 In our study, both men and women had an association between CFPWV (a global measure of aortic stiffness) and GLS. However, only women had an association between Zc (a local measure of proximal aortic stiffness) and GLS. Previous studies have found that increased proximal aortic stiffness (evaluated as Zc) is associated with impaired diastolic function measures and prevalence of diastolic dysfunction in women only.60 Additionally, the amount of elastic energy stored as a result of systolic proximal aortic stretch has been shown to relate to improved early diastolic filling in older men but not older women,12 indicating that women may fail to recover this energy as a facilitator of longitudinal LV recoil and enhanced early diastolic filling. Volumetric diastolic filling and work stored during aortic stretch were not evaluated in this study, but the observed sex differences in the relation between GLS and Zc may be linked to sex differences in diastolic function. CFPWV is closely associated with stiffening of the aortic wall, while Zc is more sensitive to differences in aortic diameter.62, 63 Women have genetically smaller aortas than men, which may limit the amount of aortic remodeling possible in response to increased hemodynamic load, for example, as a consequence of midlife weight gain. The disparity in the relations of CFPWV and Zc with GLS for men and women may be attributable in part to the markedly higher Zc values observed in women in our older sample. CFPWV and Zc also differ in their associations with GCS. CFPWV was associated with GLS and not GCS, which may indicate that long‐axis function of the LV is more closely linked with global aortic wall stiffness than is short‐axis function. In prior work conducted in this study sample, we have observed that CFPWV is significantly associated with measures of LV diastolic function but not with conventional measures of LV systolic function.48 In light of these prior results, the lack of association of CFPWV with circumferential strain is consistent with the concept that mechanical (ie, non‐hemodynamic) coupling is selectively related to LV function in the long axis. Zc was associated with both GLS and GCS, which may be related to the strong association between Zc and pressure pulsatility,62 possibly contributing to a secondary association between pressure pulsatility (which imposes an omnidirectional load) and global LV load that includes GCS.64 Additional research is needed to investigate differences in relations of CFPWV and Zc with LV function. Our study has limitations that should be considered. The study sample included middle‐aged to older men and women of predominantly European ancestry. Thus, additional studies should be performed in other age groups and ethnicities to establish the generalizability of our results. We and others have previously reported on associations of arterial stiffness in relation to adverse cardiovascular events and on the relation of altered myocardial long‐axis strain with all‐cause mortality.4, 65, 66 For the present study sample, in whom both arterial stiffness and myocardial strain measures were performed, the limited number of total events adjudicated to date precludes adequately powered analyses of their combined effects on outcomes. Because repeated measures of both arterial stiffness and myocardial strain were not available in our sample, further studies are needed to conduct longitudinal analyses of these measures also in relation to outcomes. The extent to which certain medications that might confer de‐stiffening properties may have been more or less prevalent among certain subgroups in our study sample could not be precisely ascertained. Further investigations, including prospective studies, are needed to determine the effects of medications with de‐stiffening properties on the observed relationships between arterial stiffness and LV mechanical function. Additionally, although not available in our study sample, measurements of aortic strain and ascending aorta dimension warrant attention in future studies as variation in these measures could account for at least some of our observed major findings, including differences between men and women. The strength of our study is the large community‐based sample of well‐characterized participants with routine ascertainment of comprehensive echocardiography and aortic stiffness measures.

Conclusion

Aortic stiffness is linked to LV function perhaps partially through direct mechanical coupling. During systole, LV long‐axis shortening produces longitudinal aortic stretch. As the aorta stiffens with advancing age or disease, the force required to stretch the proximal aorta will increase, which will increase load on the long axis of the LV and may result in less LV long axis shortening. In our study, both men and women exhibited a relation between increased global aortic wall stiffness, as evaluated by CFPWV, and impaired GLS, whereas only women exhibited a relation between increased proximal aortic stiffness, as evaluated by Zc, and GLS. Future studies should explore the relations between different measures of aortic stiffness and LV function and investigate possible sex differences in these relations.

Sources of Funding

This work was supported by the Ellison Foundation (Cheng), the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01‐HC‐25195) and HHSN268201500001I (Vasan), and the following grants: T32 GM74905 (McCabe), R00HL107642 (Cheng), R01HL131532 (Cheng), R01HL093328 (Vasan), R01HL107385 (Vasan, Mitchell), and R01HL126136 (Vasan, Mitchell).

Disclosures

Dr Mitchell is the owner of Cardiovascular Engineering, Inc, a company that develops and manufactures devices to measure vascular stiffness, and serves as a consultant to and has received honoraria and grants from Novartis, Merck, Servier, and Philips. Ms Bell is an employee of Cardiovascular Engineering, Inc.
  66 in total

1.  Heart motion adapted cine phase-contrast flow measurements through the aortic valve.

Authors:  S Kozerke; M B Scheidegger; E M Pedersen; P Boesiger
Journal:  Magn Reson Med       Date:  1999-11       Impact factor: 4.668

2.  Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.

Authors:  Viviane M Conraads; Marco Metra; Otto Kamp; Gilles W De Keulenaer; Burkert Pieske; José Zamorano; Panos E Vardas; Michael Böhm; Livio Dei Cas
Journal:  Eur J Heart Fail       Date:  2011-12-06       Impact factor: 15.534

3.  Enhanced ventricular untwisting during exercise: a mechanistic manifestation of elastic recoil described by Doppler tissue imaging.

Authors:  Yuichi Notomi; Maureen G Martin-Miklovic; Stephanie J Oryszak; Takahiro Shiota; Dimitri Deserranno; Zoran B Popovic; Mario J Garcia; Neil L Greenberg; James D Thomas
Journal:  Circulation       Date:  2006-05-22       Impact factor: 29.690

4.  Gender-specific differences in myocardial deformation and aortic stiffness at rest and dobutamine stress.

Authors:  Valentina O Puntmann; Eike Nagel; Alun D Hughes; Rolf Gebker; Nicholas Gaddum; Phil Chowienczyk; Cosima Jahnke; Jesus Mirelis; Bernhard Schnackenburg; Ingo Paetsch; Eckart Fleck
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

5.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination.

Authors:  Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy
Journal:  Am J Epidemiol       Date:  2007-03-19       Impact factor: 4.897

Review 6.  Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.

Authors:  Kannayiram Alagiakrishnan; Maciej Banach; Linda G Jones; Subrata Datta; Ali Ahmed; Wilbert S Aronow
Journal:  Ann Med       Date:  2012-03-13       Impact factor: 4.709

7.  Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot.

Authors:  Gerhard-Paul Diller; Aleksander Kempny; Emmanouil Liodakis; Rafael Alonso-Gonzalez; Ryo Inuzuka; Anselm Uebing; Stefan Orwat; Konstantinos Dimopoulos; Lorna Swan; Wei Li; Michael A Gatzoulis; Helmut Baumgartner
Journal:  Circulation       Date:  2012-04-11       Impact factor: 29.690

8.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

9.  Aortic stiffness is related to left ventricular diastolic function in patients with diabetes mellitus type 1: assessment with MRI and speckle tracking strain analysis.

Authors:  Linda D van Schinkel; Dominique Auger; Saskia G C van Elderen; Nina Ajmone Marsan; Victoria Delgado; Hildo J Lamb; Arnold C T Ng; Johannes W A Smit; Jeroen J Bax; Jos J M Westenberg; Albert de Roos
Journal:  Int J Cardiovasc Imaging       Date:  2012-09-22       Impact factor: 2.357

10.  Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen.

Authors:  I Raymond; F Pedersen; F Steensgaard-Hansen; A Green; M Busch-Sorensen; C Tuxen; J Appel; J Jacobsen; D Atar; P Hildebrandt
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

View more
  19 in total

1.  Actigraphy-based sleep characteristics and aortic stiffness: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Jeongok G Logan; Hyojung Kang; Jennifer Mason Lobo; Min-Woong Sohn; Gen-Min Lin; Joao A C Lima; Naresh M Punjabi; Susan Redline; Younghoon Kwon
Journal:  J Am Soc Hypertens       Date:  2018-09-29

2.  Early Wave Reflection and Pulse Wave Velocity Are Associated with Diastolic Dysfunction in Rheumatoid Arthritis.

Authors:  Lebogang Mokotedi; Sulé Gunter; Chanel Robinson; Frederic Michel; Ahmed Solomon; Gavin R Norton; Angela J Woodiwiss; Linda Tsang; Patrick H Dessein; Aletta M E Millen
Journal:  J Cardiovasc Transl Res       Date:  2019-05-22       Impact factor: 4.132

Review 3.  Hypertension and Organ Damage in Women.

Authors:  Maria Lorenza Muiesan; Anna Paini; Carlo Aggiusti; Fabio Bertacchini; Claudia Agabiti Rosei; Massimo Salvetti
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-06-26

Review 4.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

Review 5.  The Mechanobiology of Vascular Remodeling in the Aging Lung.

Authors:  Paul B Dieffenbach; Aja Aravamudhan; Laura E Fredenburgh; Daniel J Tschumperlin
Journal:  Physiology (Bethesda)       Date:  2021-09-13

Review 6.  Sex Differences in Molecular Mechanisms of Cardiovascular Aging.

Authors:  Vanessa Dela Justina; Jéssica S G Miguez; Fernanda Priviero; Jennifer C Sullivan; Fernanda R Giachini; R Clinton Webb
Journal:  Front Aging       Date:  2021-09-10

7.  Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life.

Authors:  Chike C Nwabuo; Yuichiro Yano; Henrique T Moreira; Duke Appiah; Henrique D Vasconcellos; Queen N Aghaji; Anthony Viera; Jamal S Rana; Ravi V Shah; Venkatesh L Murthy; Norrina B Allen; Pamela J Schreiner; Donald M Lloyd-Jones; João A C Lima
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

Review 8.  Aortic stiffness, pressure and flow pulsatility, and target organ damage.

Authors:  Gary F Mitchell
Journal:  J Appl Physiol (1985)       Date:  2018-10-25

Review 9.  Sex Differences in Cardiovascular Aging and Heart Failure.

Authors:  Andrew Oneglia; Michael D Nelson; C Noel Bairey Merz
Journal:  Curr Heart Fail Rep       Date:  2020-09-28

Review 10.  Mechanobiological Feedback in Pulmonary Vascular Disease.

Authors:  Paul B Dieffenbach; Marcy Maracle; Daniel J Tschumperlin; Laura E Fredenburgh
Journal:  Front Physiol       Date:  2018-07-25       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.